A man misdiagnosed with Non-Hodgkin lymphoma, who took cannabis instead of the expensive treatment, leading to a drug debt ...

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.

The Leukemia and Lymphoma Society is hosting a fundraiser to support the research of cancers such as leukemia and lymphoma on ...

Recognizing the signs and symptoms that signal the coming of the end of life for people with lymphoma can help their loved ...

An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis fungoides.

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Scientists from the University of Southern Denmark (SDU) and the University of Helsinki have now found a potential link ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Tattoos larger than the palm of a hand more than double a person's risk of skin cancer and nearly triple their risk of ...

Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.